Cargando…
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
Autores principales: | de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L., Jalving, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463864/ https://www.ncbi.nlm.nih.gov/pubmed/37635223 http://dx.doi.org/10.1186/s13046-023-02800-3 |
Ejemplares similares
-
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
por: de Heer, E. C., et al.
Publicado: (2023) -
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation
por: Zois, Christos E., et al.
Publicado: (2022) -
Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis
por: Zwager, Mieke C., et al.
Publicado: (2023) -
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer
por: Guerrero Llobet, Sergi, et al.
Publicado: (2020) -
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
por: van Sluis, Joyce, et al.
Publicado: (2020)